PCN172 Evaluation of Real-World Evidence (RWE) Used within Health Technology Assessments (HTA) in Oncology with Pivotal Single-Arm Trials: A Comparative Study of Six HTA Agencies
Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.263
https://www.valueinhealthjournal.com/article/S1098-3015(21)00480-0/fulltext
Section Title :
Section Order :
10838
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00480-0&doi=10.1016/j.jval.2021.04.263